167 related articles for article (PubMed ID: 14559095)
21. Inhibitors of the herbicidal target IspD: allosteric site binding.
Witschel MC; Höffken HW; Seet M; Parra L; Mietzner T; Thater F; Niggeweg R; Röhl F; Illarionov B; Rohdich F; Kaiser J; Fischer M; Bacher A; Diederich F
Angew Chem Int Ed Engl; 2011 Aug; 50(34):7931-5. PubMed ID: 21766403
[No Abstract] [Full Text] [Related]
22. Targeting the methyl erythritol phosphate (MEP) pathway for novel antimalarial, antibacterial and herbicidal drug discovery: inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase (DXR) enzyme.
Singh N; Chevé G; Avery MA; McCurdy CR
Curr Pharm Des; 2007; 13(11):1161-77. PubMed ID: 17430177
[TBL] [Abstract][Full Text] [Related]
23. A Bioinorganic Approach to Fragment-Based Drug Discovery Targeting Metalloenzymes.
Cohen SM
Acc Chem Res; 2017 Aug; 50(8):2007-2016. PubMed ID: 28715203
[TBL] [Abstract][Full Text] [Related]
24. Methylerythritol phosphate pathway to isoprenoids: kinetic modeling and in silico enzyme inhibitions in Plasmodium falciparum.
Singh VK; Ghosh I
FEBS Lett; 2013 Sep; 587(17):2806-17. PubMed ID: 23816706
[TBL] [Abstract][Full Text] [Related]
25. Peptide deformylase inhibitors.
Aubart K; Zalacain M
Prog Med Chem; 2006; 44():109-43. PubMed ID: 16697896
[No Abstract] [Full Text] [Related]
26. Metalloenzymes as Therapeutic Targets.
Richichi B; Spyroulias GA; Winum JY; Žalubovskis R
Curr Med Chem; 2019; 26(15):2556-2557. PubMed ID: 31453777
[No Abstract] [Full Text] [Related]
27. UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase of Escherichia coli is a zinc metalloenzyme.
Jackman JE; Raetz CR; Fierke CA
Biochemistry; 1999 Feb; 38(6):1902-11. PubMed ID: 10026271
[TBL] [Abstract][Full Text] [Related]
28. Peptide deformylase as an antibacterial target: a critical assessment.
Leeds JA; Dean CR
Curr Opin Pharmacol; 2006 Oct; 6(5):445-52. PubMed ID: 16904375
[TBL] [Abstract][Full Text] [Related]
29. Anti-malarial drug targets: screening for inhibitors of 2C-methyl-D-erythritol 4-phosphate synthase (IspC protein) in Mediterranean plants.
Kaiser J; Yassin M; Prakash S; Safi N; Agami M; Lauw S; Ostrozhenkova E; Bacher A; Rohdich F; Eisenreich W; Safi J; Golan-Goldhirsh A
Phytomedicine; 2007 Apr; 14(4):242-9. PubMed ID: 17293098
[TBL] [Abstract][Full Text] [Related]
30. Structure-based discovery of LpxC inhibitors.
Zhang J; Chan A; Lippa B; Cross JB; Liu C; Yin N; Romero JA; Lawrence J; Heney R; Herradura P; Goss J; Clark C; Abel C; Zhang Y; Poutsiaka KM; Epie F; Conrad M; Mahamoon A; Nguyen K; Chavan A; Clark E; Li TC; Cheng RK; Wood M; Andersen OA; Brooks M; Kwong J; Barker J; Parr IB; Gu Y; Ryan MD; Coleman S; Metcalf CA
Bioorg Med Chem Lett; 2017 Apr; 27(8):1670-1680. PubMed ID: 28302397
[TBL] [Abstract][Full Text] [Related]
31. Planting the seeds of new antimalarial drugs.
Ridley RG
Science; 1999 Sep; 285(5433):1502-3. PubMed ID: 10498534
[No Abstract] [Full Text] [Related]
32. Reverse fosmidomycin derivatives against the antimalarial drug target IspC (Dxr).
Behrendt CT; Kunfermann A; Illarionova V; Matheeussen A; Pein MK; Gräwert T; Kaiser J; Bacher A; Eisenreich W; Illarionov B; Fischer M; Maes L; Groll M; Kurz T
J Med Chem; 2011 Oct; 54(19):6796-802. PubMed ID: 21866890
[TBL] [Abstract][Full Text] [Related]
33. Recent Process in the Inhibitors of UDP-3-O-(R-3-hydroxyacyl)-Nacetylglucosamine Deacetylase (LpxC) Against Gram-Negative Bacteria.
Liu F; Ma S
Mini Rev Med Chem; 2018; 18(4):310-323. PubMed ID: 27739357
[TBL] [Abstract][Full Text] [Related]
34. Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor.
Chen DZ; Patel DV; Hackbarth CJ; Wang W; Dreyer G; Young DC; Margolis PS; Wu C; Ni ZJ; Trias J; White RJ; Yuan Z
Biochemistry; 2000 Feb; 39(6):1256-62. PubMed ID: 10684604
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, antibacterial activity, and biological evaluation of formyl hydroxyamino derivatives as novel potent peptide deformylase inhibitors against drug-resistant bacteria.
Yang S; Shi W; Xing D; Zhao Z; Lv F; Yang L; Yang Y; Hu W
Eur J Med Chem; 2014 Oct; 86():133-52. PubMed ID: 25151577
[TBL] [Abstract][Full Text] [Related]
36. Bacterial Peptide deformylase inhibitors: a new class of antibacterial agents.
Jain R; Chen D; White RJ; Patel DV; Yuan Z
Curr Med Chem; 2005; 12(14):1607-21. PubMed ID: 16022661
[TBL] [Abstract][Full Text] [Related]
37. Crystal structure of LpxC from Pseudomonas aeruginosa complexed with the potent BB-78485 inhibitor.
Mochalkin I; Knafels JD; Lightle S
Protein Sci; 2008 Mar; 17(3):450-7. PubMed ID: 18287278
[TBL] [Abstract][Full Text] [Related]
38. LpxC (UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase) inhibitors: A long path explored for potent drug design.
Kumar Pal S; Kumar S
Int J Biol Macromol; 2023 Apr; 234():122960. PubMed ID: 36565833
[TBL] [Abstract][Full Text] [Related]
39. Zinc hydrolases: the mechanisms of zinc-dependent deacetylases.
Hernick M; Fierke CA
Arch Biochem Biophys; 2005 Jan; 433(1):71-84. PubMed ID: 15581567
[TBL] [Abstract][Full Text] [Related]
40. Metalloenzyme inhibitors for the treatment of Gram-negative bacterial infections: a patent review (2009-2012).
Supuran CT; Carta F; Scozzafava A
Expert Opin Ther Pat; 2013 Jul; 23(7):777-88. PubMed ID: 23458841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
